Shares of Healthpeak Properties Inc. DOC slipped 2.52% to $18.17 Thursday, on what proved to be an all-around rough trading ...

HealthEquity, Inc. stock has a Momentum Score of 54 ... hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider ...

Jefferies Financial Group. "Jefferies Announces First Quarter 2025 Financial Results." RH Stock Plunges 40% on Weak Earnings, Worries About Trump Tariffs. Other Furniture Stocks Fall, Too.

Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started ...

HealthEquity stock’s recent year-to-date underperformance is partly due to its disclosure of fraud against some of its HSA customers and near-term investor concerns about recent management changes.

The firm currently has an overweight rating on the stock. Several other brokerages have also recently weighed in on HQY. Royal Bank of Canada boosted their target price on HealthEquity from $100. ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value, with ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value ...

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthequity with a $ ... also maintained a Buy rating on the stock with a $126.00 price target.

HealthEquity divulged its fourth-quarter and full-year fiscal 2024 results just after market close on Tuesday. These showed that the company earned $311.8 million for the period ended Jan. 31 ...